HM
RGLS

HealthCor Management’s Regulus Therapeutics RGLS Stock Holding History

HealthCor Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-12,917
Closed -$10.6M – 55
2014
Q3 		$10.6M Hold
12,917
– – 0.54% 36
2014
Q2 		$12.5M Sell
12,917
-208
-2% -$178K 0.62% 35
2014
Q1 		$14.2M Sell
13,125
-1,458
-10% -$1.62M 0.85% 31
2013
Q4 		$12.9M Buy
14,583
+6,458
+79% +$5.56M 0.79% 36
2013
Q3 		$9.19M Buy
+8,125
New +$9.59M 0.49% 44

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management's RGLS Position: Q4 2014 in Review

HealthCor Management sold out of Regulus Therapeutics (RGLS) in Q4 2014, closing a stake of 12,917 shares — an estimated $10.6M sold.

HealthCor Management first reported a position in RGLS in Q3 2013 and held it in 5 quarters. The position peaked at $14.2M in Q1 2014. 83 funds tracked by Wall St. Rank hold RGLS as of Q4 2014.

  • HealthCor Management reported no remaining Regulus Therapeutics position as of Q4 2014 after selling out during the quarter.
  • HealthCor Management sold 12,917 Regulus Therapeutics shares in Q4 2014, an estimated $10.6M.
  • HealthCor Management first reported a position in Regulus Therapeutics in Q3 2013 and held it in 5 quarters.
  • HealthCor Management's Regulus Therapeutics position peaked at $14.2M in Q1 2014.
  • 83 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2014.

Based on HealthCor Management's 13F filing for Q4 2014, filed 17 Feb 2015.